Intellia Therapeutics Announces Upcoming Financial Results Call

Author: Owen Jenkins Updated: 05-01-2025 07:32 AM

Intellia Therapeutics Holds Conference Call for Q1 Earnings

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a pioneering force in gene editing, is gearing up to unveil its first quarter 2025 financial results. The conference call, scheduled for May 8, 2025, at 8 a.m. ET, promises to shed light on the company's operational highlights and future aspirations.

How to Join the Conference Call

For anyone interested in participating, U.S. callers can reach the conference by dialing 1-833-316-0545, while international callers should use 1-412-317-5726. It is advisable to connect about five minutes prior to the call to ensure a smooth entry. Be sure to ask for the Intellia Therapeutics conference call when connecting.

Accessing Live Webcast

Participants can also tune in to a live webcast of the conference call. Details for accessing the webcast can be found through the company’s official channels, ensuring that no one misses out on the crucial updates shared by the management team.

Replay Availability

Following the live event, a replay of the conference call will be accessible via the Events and Presentations page within the Investors & Media section of Intellia’s website. Starting from 12 p.m. ET on May 8, 2025, those who couldn’t join the live call will have the opportunity to catch up on all discussions and key points highlighted.

About Intellia Therapeutics

Founded with a vision to transform medicine, Intellia Therapeutics, Inc. stands at the forefront of gene editing technology, employing CRISPR-based therapies to tackle significant medical challenges. The company's commitment to innovation drives its development of groundbreaking treatments aimed at fulfilling unmet medical needs. Through a combination of scientific prowess and clinical experience, Intellia is establishing new standards within the healthcare landscape.

Innovations in Gene Editing

Intellia continues to advance its gene editing platform, exploring novel delivery methods and technologies that expand the capabilities and efficacy of its treatments. By harnessing the potential of CRISPR, the company is poised to redefine treatment paradigms and significantly impact patient outcomes.

Intellia Therapeutics Contacts

For investor inquiries, please reach out to:

Brittany Chaves
Senior Manager, Investor Relations
brittany.chaves@intelliatx.com

Frequently Asked Questions

What is the purpose of the conference call?

The conference call aims to present Intellia Therapeutics' first quarter 2025 financial results and operational updates.

When is the conference call scheduled?

The call is set for May 8, 2025, at 8 a.m. ET.

How can I listen to the conference call?

Interested participants can join by dialing the designated phone numbers or by accessing the live webcast.

Will a replay be available for the conference call?

Yes, a replay will be accessible from 12 p.m. ET on May 8, 2025, via Intellia’s website.

What makes Intellia Therapeutics unique?

Intellia is distinguished by its pioneering work in CRISPR-based gene editing, focusing on developing first-in-class medicines to address critical medical needs.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.